{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:36:38Z","timestamp":1779122198508,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.03.104","type":"journal-article","created":{"date-parts":[[2011,4,23]],"date-time":"2011-04-23T02:04:28Z","timestamp":1303524268000},"page":"4195-4201","source":"Crossref","is-referenced-by-count":18,"title":["Live attenuated rabies virus co-infected with street rabies virus protects animals against rabies"],"prefix":"10.1016","volume":"29","author":[{"given":"Xianfu","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Franka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.03.104_bib0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/00365540701596003","article-title":"Evaluation of a two-dose administration of live oral poliovirus vaccine for wild and virulent vaccine-derived poliovirus type 1, 2, 3 strains in Japan","volume":"40","author":"Iwai","year":"2008","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0010","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1016\/j.vaccine.2008.09.076","article-title":"Effective and safe immunization with live-attenuated vaccines for children after living donor liver transplantation","volume":"26","author":"Shinjoh","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00148581-200810050-00007","article-title":"Live attenuated measles, mumps, rubella, and varicella zoster virus vaccine (Priorix-Tetra)","volume":"10","author":"Dhillon","year":"2008","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00063030-199810040-00001","article-title":"Herpesvirus vaccines: an update","volume":"10","author":"Jennings","year":"1998","journal-title":"BioDrugs"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0025","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.vaccine.2008.01.021","article-title":"A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses","volume":"26","author":"Sohn","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0030","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.vaccine.2007.12.035","article-title":"Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17D live attenuated yellow fever first-time vaccination","volume":"26","author":"Martins","year":"2008","journal-title":"Vaccine"},{"issue":"RR-2","key":"10.1016\/j.vaccine.2011.03.104_bib0035","first-page":"1","article-title":"Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies: recommendations of the advisory committee on immunization practices","volume":"59","author":"Rupprecht","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0040","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4049\/jimmunol.79.5.428","article-title":"The submerged culture of mammalian cells: the spinner culture","volume":"79","author":"McLimans","year":"1957","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.biologicals.2008.06.004","article-title":"An overview of animal cell substrate for biological products","volume":"36","author":"Petricciani","year":"2008","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4049\/jimmunol.93.3.353","article-title":"Cultivation of rabies virus in human diploid cell strain WI-38","volume":"93","author":"Wiktor","year":"1964","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2007.07.018","article-title":"Glycoprotein gene relocation in rabies virus","volume":"131","author":"Wu","year":"2008","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0060","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2007.06.022","article-title":"Are all lyssavirus genes equal for phylogenetic analyses?","volume":"129","author":"Wu","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0065","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1128\/JVI.76.9.4153-4161.2002","article-title":"Both viral transcription and replication are reduced when the rabies virus nucleoprotein is not phosphorylated","volume":"76","author":"Wu","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0070","doi-asserted-by":"crossref","first-page":"12554","DOI":"10.1128\/JVI.79.19.12554-12565.2005","article-title":"Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system","volume":"79","author":"Wang","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0075","first-page":"413","article-title":"Immune evasion, a critical strategy for rabies virus","volume":"131","author":"Lafon","year":"2008","journal-title":"Dev Biol (Basel)"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4049\/jimmunol.72.1.85","article-title":"Studies on chick embryo adapted rabies virus. V. Protection of animals with antiserum and living attenuated virus after exposure to street strain of rabies virus","volume":"72","author":"Koprowski","year":"1954","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0085","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1016\/j.vaccine.2009.09.034","article-title":"Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies viruses","volume":"27","author":"Franka","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0090","series-title":"Who goes first? The story of self-experimentation in medicine","first-page":"92","year":"1998"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0095","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2105\/AJPH.41.12.1483","article-title":"Recent developments in the prophylaxis of rabies","volume":"41","author":"Koprowski","year":"1951","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0100","unstructured":"World Health Organization Technical Report Series. No. 82, Expert Committee on Rabies, 2nd Report, April 1954:1\u201327."},{"key":"10.1016\/j.vaccine.2011.03.104_bib0105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3181\/00379727-47-13084P","article-title":"Immunological properties of an antibody-containing fluorescent group","volume":"47","author":"Coons","year":"1941","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0002-9343(91)90161-P","article-title":"Confirmed rabies exposure during pregnancy: treatment with human rabies globulin and human diploid cell vaccine","volume":"91","author":"Chabala","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0115","first-page":"229","article-title":"Post-exposure prophylaxis with purified vero cell vaccine during pregnancy-safety and immunogenicity","volume":"31","author":"Sudarshan","year":"1999","journal-title":"J Commun Dis"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4161\/hv.3.3.4010","article-title":"Assessing the safety of post-exposure rabies immunization in pregnancy","volume":"3","author":"Sudarshan","year":"2007","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0125","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.vaccine.2004.08.036","article-title":"Rabies post-exposure prophylaxis in malnourished children exposed to suspect rabid animals","volume":"23","author":"Sampath","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0130","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.vaccine.2005.03.059","article-title":"Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children","volume":"24","author":"Chulasugandha","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0264-410X(89)90050-9","article-title":"Comparative study of the safety and protective value, in pre-exposure use, of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on Vero cells","volume":"7","author":"Ajjan","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0140","first-page":"747","article-title":"Comparative studies on chick embryo cell rabies vaccine and human diploid cell vaccine: pre-exposure use and purity of the vaccines","volume":"24","author":"Arai","year":"1993","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0145","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/S0264-410X(98)00064-4","article-title":"Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV)","volume":"16","author":"Dietzschold","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1086\/520143","article-title":"A new Vero cell rabies vaccine: results of a comparative trial with human diploid cell rabies vaccine in children","volume":"29","author":"Sabchareon","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0155","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1016\/S0264-410X(01)00238-9","article-title":"Immunogenicity, safety and lot consistency in adults of a chromatographically purified Vero-cell rabies vaccine: a randomized, double-blind trial with human diploid cell rabies vaccine","volume":"19","author":"Jones","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0160","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4049\/jimmunol.60.4.533","article-title":"Studies on chick embryo adapted rabies virus. I. Culture characteristics and pathogenicity","volume":"60","author":"Koprowski","year":"1948","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0165","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/jimmunol.64.3.185","article-title":"Studies on chick embryo adapted rabies virus. II. Pathogenicity for dogs and use of egg-adapted strains for vaccination purpose","volume":"64","author":"Koprowski","year":"1950","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4049\/jimmunol.72.1.79","article-title":"Studies on chick embryo adapted rabies virus. IV. Immunization of Guinea-pigs and description of a potency control test","volume":"72","author":"Koprowski","year":"1954","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0175","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4049\/jimmunol.72.1.94","article-title":"Studies on chick embryo adapted rabies virus. VI. Further changes in pathogenic properties following prolonged cultivation in the developing chick embryo","volume":"72","author":"Koprowski","year":"1954","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0180","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4049\/jimmunol.72.6.503","article-title":"Studies on chick embryo adapted rabies virus. VII. Immunological responses of animals to vaccination with high egg passage Flury strain","volume":"72","author":"Koprowski","year":"1954","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0185","first-page":"221","article-title":"Further studies on the use of ERA rabies vaccine in domestic animals","volume":"8","author":"Abelseth","year":"1967","journal-title":"Can Vet J"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7589\/0090-3558-44.1.71","article-title":"ERA vaccine-derived cases of rabies in wildlife and domestic animals in Ontario Canada, 1989\u20132004","volume":"44","author":"Fehlner-Gardiner","year":"2008","journal-title":"J Wildl Dis"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005072-199401000-00001","article-title":"Rabies encephalitis in humans: pathology, pathogenesis and pathophysiology","volume":"53","author":"Mark","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0200","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-510X(89)90178-0","article-title":"Regional distribution of rabies viral antigens in central nervous system of human encephalitic and paralytic rabies","volume":"92","author":"Tirawatnpong","year":"1989","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0205","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10875-006-9044-0","article-title":"Detection of cellular immunity to rabies antigens in human vaccinees","volume":"26","author":"Moore","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/IAI.35.1.213-221.1982","article-title":"Dual role of the immune responses in street rabies virus infection of mice","volume":"35","author":"Smith","year":"1982","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/13550280009018300","article-title":"Abortive rabies virus central nervous infection is controlled by T lymphocyte local recruitment and induction of apoptosis","volume":"6","author":"Galelli","year":"2000","journal-title":"J Neurovirol"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0220","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/S0264-410X(00)00321-2","article-title":"Humoral and cell-mediated immune responses of foxes (Vulpes vulpes) after experimental primary and secondary oral vaccination using SAG-2 and V-RG vaccines","volume":"19","author":"Lambot","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.03.104_bib0225","first-page":"39","article-title":"Duration of immunity in foxes vaccinated orally with ERA vaccine in a bait","volume":"61","author":"Lawson","year":"1997","journal-title":"Can J Vet Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1100507X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1100507X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T12:41:59Z","timestamp":1686055319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1100507X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":45,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X1100507X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.104","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}